Opko Health OPK
NASDAQ OPK
$1.60 -0.06 (-3.61%)
At close: Oct 21, 2026 · 4:00 PM EDT

Opko Health (OPK) Land & Improvements (2011 - 2012)

Updated

Opko Health's Land & Improvements came in at $2.62 million for Q4 2012, up 499.3% from $437,000 a year earlier.

Analysis

Opko Health (OPK) Land & Improvements (2011 - 2012) Analysis & Trends

  • Going back by year, Land & Improvements was $437,000 in FY2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Land & Improvements (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Opko Health 1.21 Bn -214.71 Mn 80.02 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2012 2.62 Mn
Dec 31, 2011 437,000.00
API Access

Opko Health Land & Improvements API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=land-and-improvements&ticker=OPK&period=max&api_key=YOUR_API_KEY